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Abstract
The genome-wide association study (GWAS) has become a routine approach for mapping disease risk loci with the advent
of large-scale genotyping technologies. Multi-allelic haplotype markers can provide superior power compared with single-
SNP markers in mapping disease loci. However, the application of haplotype-based analysis to GWAS is usually bottlenecked
by prohibitive time cost for haplotype inference, also known as phasing. In this study, we developed an efficient approach
to haplotype-based analysis in GWAS. By using a reference panel, our method accelerated the phasing process and reduced
the potential bias generated by unrealistic assumptions in phasing process. The haplotype-based approach delivers great
power and no type I error inflation for association studies. With only a medium-size reference panel, phasing error in our
method is comparable to the genotyping error afforded by commercial genotyping solutions.
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Introduction
The availability of inexpensive platforms for performing dense
single nucleotide polymorphism (SNP) analysis makes it possible
and affordable to conduct GWAS of complex diseases. Nearly 800
risk SNPs have been reported from over 600 genome-wide
association studies in the past years [1].
Power to detect disease susceptibility loci is an essential
consideration in the design of GWAS. Researchers have compared
the power of single-SNP and haplotype-based association analysis in
different genetic scenarios. The benefit of including haplotype-
tagging SNPs, especially those based on a cluster of 2–3 SNP
markers, has been well recognized after the discovery of ‘‘block-like’’
linkage disequilibrium (LD) pattern in human genome [2].
Theoretical studies demonstrated that the use of multi-allelic
haplotypes significantly improved the power and robustness of
association studies [3]. This theoretical analysis has been well
supported byassociationstudiesformanydifferent traits.Haplotypes
conferring high susceptibility were identified for schizophrenia,
nicotine dependence and macular degeneration for example [4–6].
However, two technical issues may hinder the implementation of
multi-allelic haplotype-based analysis in GWAS. On the one hand,
the inference of haplotypes, also known as phasing, is time-consuming
given the huge number of geneticm a r k e r si nG W A S .N u m e r o u s
efforts have gone into developing time-saving algorithms, such as
fastPHASE, Haplotyper, Hap, Beagle, MACH and 2SNP etc., for
example [7–12]. Most of these programs are still difficult to apply for
routine use in GWAS, although Beagle has shown preliminary success
[13]. PLINK implemented a standard expectation maximization
algorithm to conduct haplotype-based analysis but phasing quality of
the standard EM algorithm is still unknown when applied to GWAS
data [14]. On the other hand, HWE and other assumptions in
phasing process may lead to problems in GWAS such as decreased
phasing quality and statistical bias although some phasing algorithms
showed robustness to departures from the assumptions [12,15,16].
Due to the nature of the sampling strategy in case-control studies, the
problems that result from such assumptions may emerge with the
markers surrounding high-risk loci. Permutation supplies a possible
solution to eliminate bias in statistical tests but it entails an even more
prohibitive time cost. The development of a fast algorithm with
robustness to the departure from assumptions would greatly benefit
statistical test and data mining in GWAS.
In this report, we present an efficient method utilizing pre-
selected SNP clusters and reference phylogeny to improve data
PLoS ONE | www.plosone.org 1 July 2011 | Volume 6 | Issue 7 | e22097analysis in GWAS. This efficient approach delivers a great power
than single-SNP analysis and introduces little bias to the statistical
analysis.
Results
Accuracy of haplotype reconstruction from phase-known
reference panel
We proposed a sampling model to study sampling process of a
phase-known reference panel. The reference panel included
haplotype information from dozens or hundreds of individuals.
As the haplotypes observed in the reference panel is a subset of all
the existing haplotypes of a natural population due to limited
samples in the reference panel, we classify all the existing
haplotypes into two groups, named ‘‘observed’’ and ‘‘unobserved’’
groups. The haplotypes presented in the reference panel are
‘‘observed’’ haplotypes and the absent haplotypes are ‘‘unob-
served’’ haplotypes.
Given p as overall frequency of the ‘‘unobserved’’ haplotypes in
a natural population, a two-step sampling process can generate a
subpopulation (size n) with or without the ‘‘unobserved’’
haplotypes. In the first step, n random number {f1, f2,… fi,
…fn} are generated with uniform distribution in the range from 0
to 1. In the second step, chromosomes are sampled sequentially
from the population following the rules below.
a. When fi.p, a chromosome carrying ‘‘observed’’ haplotype
was added to the sample set.
b. If fi#p, a chromosome carrying ‘‘unobserved’’ haplotype was
added.
Under the rules, none of the ‘‘unobserved’’ haplotypes appears
in the sample set when min{fi}.p.
Overall frequency of ‘‘unobserved’’ haplotypes in natural
population is unknown. Given 1-p. .p, we treat E(fmin)a sa n
upper bound of p when size of the phase-known reference panel
(n) is large.
The cumulative distribution function (CDF) of min{fi}i s
Pr jminƒx ðÞ ~1{ 1{x ðÞ
n:
The expectation of min{fi} can be calculated in
E jmin ðÞ ~
ð 1
0
xd 1{ 1{x ðÞ
n ½  ~
1
nz1
: ð1Þ
Using the E(fmin), phasing performance of our method could be
explored in general scenarios for GWAS. In the investigation, for
each SNP cluster in our phasing process (see method section for
details), we define that a genotype is ‘‘permitted’’ genotype if it is a
combination of two ‘‘observed’’ haplotypes.
We grouped all genotypes in GWAS study into three categories.
The ‘‘permitted’’ genotype was considered as ‘‘phase-known
genotype’’ because their haplotypes were fully determined by
perfect phylogeny of the observed haplotypes. Most of the rest
genotypes in GWAS data were a combination of one observed
haplotype and one unknown haplotype. They are considered as
‘‘predictable genotype’’ in our study because we have introduced a
phasing rule to handle this situation (see method for details). Only
a small proportion of the genotypes in GWAS data are the
combination of two unknown haplotypes. We considered those
genotypes as ‘‘phase-unknown genotypes’’.
When chromosome number (size n) of the reference panel is
large, the E(fmin) is close to p. Proportions of the three genotype
categories in GWAS data thus could be estimated in E(fmin)
2,
2E(fmin)(12E(fmin)) and (12E(fmin))
2 with the assumption of
Hardy-Weinberg equilibrium, respectively. In nature of our
approach, correct haplotype identifications in our phasing process
must be greater than the number of ‘‘phase-known genotypes’’
and slightly less than the sum number of ‘‘phase-known
genotypes’’ and ‘‘predictable genotypes’’.
Proportion of the genotype categories changed with the change
of reference population size because upper bound of unobserved
haplotype proportion E(fmin) is determined by the reference panel
size in Equation 1 (Figure 1). The result has indicated that the
performance of our method continuously improves with an
increase of reference panel size. The performance could fully
satisfy the needs of haplotype-based association studies with only a
middle-size reference panel.
To evaluate our method in real-world data, we checked phasing
errors in a 6-fold cross-validation using the phase-known CEU
dataset of HapMap Project (see method for details). Proportions of
correct phasing ranges from 99.61% to 99.63% in the validations
using reference panel with 50 unrelated individuals (Table 1). The
proportions are concordant with the above analysis upon the
proposed sampling model. This result has confirmed the above
conclusion that our method is accurate in haplotype reconstruc-
tion with a middle-size reference panel.
Proportion of unknown haplotypes (about 0.25%) in the
assessment is less than that was expected, E(fmin)<0.9% when
50 individuals were involved in reference panel (Equation 1). This
could be due to phasing error on the predictable genotypes. In this
scenario, one genotype has two (or more) possible explanations for
its haplotypes. For example, the genotype could be explained as
either combination of two observed haplotypes or one observed
haplotype with one unknown haplotype. In our method, we always
chose the first solution (two observed haplotypes) even if the later
one is actually correct (see method section for details). Most of the
phasing errors from our method were because of the incorrect
choices.
Performance in association study with simulation data
Recent progress in algorithm development has greatly improved
the performance of haplotype inference. MACH, Beagle and
2SNP etc. declared high efficiency and haplotype inference in
‘‘PHASE quality’’. We tested all the three representative
algorithms on ten simulation data sets (see method for details).
Beagle finished each of the data sets in ,2.5 hour in a single IntelH
Xeon 2.5 GHz processor core and 1.5G RAM, whereas MACH
and 2SNP finished phasing process for one data set on the same
computational platform in 68 and 75 hours, respectively. Due to
their large timing cost, MACH and 2SNPs were not considered in
following comparison because they are unlikely to be more
competitive in GWAS than Beagle. Considering GWAS involves
markers ,25–50 times greater than the simulation data sets,
Beagle is the appropriate phasing solution for GWAS among the
three candidates.
Compared to the total timing cost in Beagle (25 hours for 10
data sets), Haplominer, the program implemented our algorithm,
took only 2.6 hours to finish both the phasing process and
association analysis on all 10 data sets. The analysis is almost 10
times faster than that of Beagle.
We compared accordant rate of p-values between different
approaches using standard haplotypes and reconstructed haplo-
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haplotypes as a reference, higher accordant rate indicates more
reliable performance. Our method outperformed Beagle in the
evaluation. The accordant rate in Haplominer approach is 2%
higher than that in Beagle approach (Figure 2a). More
importantly, the accordant rate in the Haplominer approach held
constant for markers with different significance levels, while the
performance of Beagle decreased with the p-values of markers. Its
contribution increases from 59.0% to 70.5% to the total
discordant p-values (pooling all discordant results from both the
approaches) when significant level of the markers decreases from
above 0.05 to below 0.001 (Figure 2b). It was noticed that the
overlap of discordant results from different methods is relatively
small (from 4.6% to 11.8%, Figure 2b). It is therefore possible to
minimize power loss due to the phasing errors by conducting
analysis using both approaches.
Bivariate correlation analysis shows that p-values from both
Haplominer and Beagle approaches are well correlated with p-
values from the standard haplotype sets. Pearson’s coefficient is
0.999 between Beagle approach and the approach with standard
haplotypes. It is slightly higher than the coefficient (0.998) between
Haplominer approach and the standard haplotype approach.
Beagle tends to make errors on fewer individuals than Haplominer
does though Haplominer makes errors on fewer SNP clusters than
Beagle.
The other major concern is potential bias in statistical test of
GWAS, which can be conveniently examined using QQ-plot. We
plotted quantiles of p values from our method against the quantiles
of p values from standard haplotypes (Figure 3). The quantiles fit
each other well. No obvious statistical bias was observed in the
results from our method.
Application to real GWAS data
Power of multi-allelic haplotype in association study has been
well investigated in both theoretical analysis and computer
simulation [3,17]. In this report, we evaluated overall performance
of our method on both phasing and statistical test in a GWAS data
set from a rheumatoid arthritis (RA) study [18]. After initial
screen, 485,841 SNPs and 354,010 SNPs clusters were used as
single-SNP and haplotype markers in statistical test for association,
respectively. To account for multiple testing, P,1.0610
27 was
used as a universal threshold for declaring significance in both
single-SNP and haplotype-based analysis.
In the female only GWAS (with 633 cases and 846 controls),
234 single-SNP markers and 482 SNP clusters showed significant
association with RA in single-marker analysis and haplotype-based
analysis, respectively. In the male only GWAS (with 226 cases and
339 controls), the numbers of associated single-SNP markers and
SNP clusters are 84 and 148, respectively. It is obvious that
haplotype-based association analysis in our approach revealed
more significant associations with rheumatoid arthritis than single
SNP-based association analysis in both studies (Figure 4A). A large
proportion of the significant loci in haplotype-based association
studies (25.5% for females and 16.2% for male; Figure 4B) were
missed by single-SNP analyses (no SNPs from the clusters were
significant in the single-SNP analysis). In contrast, only 4.3% and
0.0% of the single SNP findings were missed in the haplotype-
based analyses (Figure 4B).
171 single SNPs and 628 SNP clusters on Chromosome 6
yielded positive associations with RA in analysis for full RA data
set (without considering gender). Given the fixed rejection
threshold, disease prevalence, effect size of disease allele, LD
Figure 1. Proportion of ‘‘phase-known genotypes’’ and ‘‘predictable genotypes’’ growths with the increase of reference panel size.
The y-axis show proportion of different genotype categories in GWAS data; number of individuals involved in reference panel was shown on x-axis.
‘‘unknown genotype’’ is only a very small proportion.
doi:10.1371/journal.pone.0022097.g001
Table 1. Performance in 6-fold cross-validation (CV) using
phased CEU data of HapMap Project.
cv1 cv2 cv3 cv4 cv5 cv6
Total haplotypes 6115180 6118780 6112460 6115120 6115720 6113780
Wrong haplotypes 23656 23104 23495 22888 23347 22751
Unknown haplotypes 14532 14849 14979 14455 14148 14867
Phasing error (%) 0.39 0.38 0.38 0.37 0.38 0.37
Unknown haplotype
(%)
0.24 0.24 0.25 0.24 0.23 0.24
Correct phasing (%) 99.61 99.62 99.62 99.63 99.62 99.63
doi:10.1371/journal.pone.0022097.t001
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association with disease status around known disease loci
(Chromosome 6p near the HLA region) in statistical tests,
indicating that haplotype-based association studies have greater
power than single SNP-based association studies (Figure 5). Our
haplotype-based analysis outperformed the single-SNP-based
analysis in the real GWAS data set.
In efficiency, Haplominer, the C++ program implementing our
method, finished the above analysis in 5.5 hours (on a single IntelH
Xeon 2.5 GHz processor core and 2G RAM, Windows XP 64bit
OS). It took Beagle 84 hours to finish only the phasing jobs for the
same data sets on the same platform.
To evaluate false positive discovery in our findings, we used
WTCCC RA data with imputed genotypes as an independent
replication for the genetic associations on Chromosome 6. Results
showed that 90.4% of the declared associations (568 in 628 SNP
clusters) were successfully replicated in WTCCC data set by
haplotype-based analysis while only 83.0% of the declared
associations (142 in 171 SNPs) were replicated by single-SNP
analysis. This finding indicated that haplotype-based study is more
robust than single-marker analysis. This is a favorable feature since
poor replication can be a serious problem in GWAS.
Discussion
Models describing genotyping errors have been well established,
but models of phasing error remain relatively scarce. For case-
control studies of genetic association, researchers have found that,
for a particular error model, known as model GLHO (Gordon,
Liu, Heath and Ott presented), there is no increase in type I error
due to errors in genotyping [19]. Study of the GLHO model
benefits our understanding to phasing error. In our method,
phasing errors are introduced to different haplotypes of different
SNP clusters in the similar manner of genotyping errors in the
model GLHO under the assumptions of random mating and
sampling. Phasing errors in our method, therefore, do not increase
type I error in GWAS when haplotypes are treated as alleles of
multi-allele markers. The conclusion is concordant with our
observation in QQ plot (Figure 3).
Both genotyping error and phasing error impact GWAS.
Comparison of identical SNPs genotyped by different platforms
provides an approximation of genotyping errors in GWAS. It has
been reported that accordant rate of genotypes between Illumina
and Affymetrix arrays is as high as 99.22–99.73% [20]. Rate of
correct phasing is 99.61–99.63% in our method with only a
middle-size reference panel (table 1). The rate will continuously
improve with increasing size of phase-known reference panel in
our approach. The phasing accuracy of our method is the same
good as genotyping accuracy of current genotyping platforms. The
phasing error is not a technical lesion in the haplotype-based
GWAS.
Some sophistic methods have been developed to use haplotypes
in association study, such as Blossoc, CLADHC, Margarita and
AncesHC etc. [21–24]. However, most of the complicate methods
would demand a noticeable CPU times for computation when the
methods worked on a huge amount of data. The methods are
therefore less efficient than our method in GWAS. Haplominer,
the same as Beagle and PLINK, directly used SNP clusters as
multi-allelic pseudo markers in association studies. Statistical tests
(Fisher’s exact test or Pearson’s chi-square test etc.) in those
methods are easy to compute and powers of the classic statistical
tests are well known in statistical theory and disease models.
Figure 2. Performance of Haplominer and Beagle-based approach in association study with simulated data. A. Percentage of
accordant p-values in the valuation with simulation data. B. Contributions of different approaches to the total discordant p-values.
doi:10.1371/journal.pone.0022097.g002
Figure 3. Q-Q plot of p-values in 2log10 scale. Quartile of p-
values from our approach was shown on y-axis and x-axis presented
quantile of p-values from analysis on raw haplotype data.
doi:10.1371/journal.pone.0022097.g003
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PLoS ONE | www.plosone.org 4 July 2011 | Volume 6 | Issue 7 | e22097Figure 4. Comparison of results from single-SNP and Haplotype-based analysis. A. Histograms of single SNPs and SNP clusters with p-value
less than 1.0610
27 in analyses for male and female data sets, respectively. B. Venn Diagrams showed the sharing of significant single SNPs and SNP
clusters in association studies for male and female data sets, respectively. A single-SNP or haplotype finding was shared with the other approach when
the significant SNP appeared in any of the significant SNP clusters or any SNP of the cluster appeared in findings of single-SNP analysis, respectively.
doi:10.1371/journal.pone.0022097.g004
Figure 5. Haplotype-based analysis is more powerful than single-SNP analysis. Upper panel shows results from single-SNP analysis; lower
panel presents results of haplotype-based analysis.
doi:10.1371/journal.pone.0022097.g005
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variety of purposes in the past two decades though tasks of the
algorithms look like similar. In 1990s, both numbers of individuals
and genetic markers are generally limited in works of haplotype
reconstruction. Efforts for algorithm development focused on
improving accuracy in phasing task with limited data size. In 2002,
the partition and ligation strategy was introduced to phasing
algorithms to handle large amount of genetic markers [12]. Soon
after that, with progresses in GWAS, efficiency as well as accuracy
became a focus for algorithm development. MACH is one of the
algorithms with high efficiency and accuracy when working on
large data set [11]. However, only Beagle was developed
specifically to handle GWAS data and had higher efficiency than
other algorithms in many scenarios [10]. Most of the aforemen-
tioned methods paid more attention on haplotype inference than
that on association study. In this report, we introduced an efficient
method for haplotype-based GWAS. Our purpose is to supply the
most efficient solution for haplotype-based association study with
thousands of individuals and millions of markers rather than
providing a method for haplotype reconstruction. Therefore, our
approach and the aforementioned phasing algorithms are running
on different tracks with different purposes. In particular, the
algorithm we developed will work best in areas of high linkage
disequilibrium.
A phase-known reference panel was utilized in our method.
Published phasing algorithm, such as PHASE, produced reliable
haplotypes for family data with error rate 0.16% or smaller [25].
Haplotype information from trios of HapMap project would serve
well as haplotype references in our method. However, phasing
errors increased when the existing algorithms worked on
genotypes of independent individuals [25]. The increase of
phasing errors may be critical when statistically phased haplotypes
of independent individuals are used as haplotype references. We
therefore examined the possibility of using statistically phased
haplotypes of independent individuals as a phase-known reference
panel. Utilizing the simulation data and evaluation methods that
were used to evaluate performance of our method above (results
presented in Figure 2 & 3), our analysis showed statistically phased
haplotypes (from Beagle) had performance very similar with the
standard haplotypes. 98.54% of total results (223634 of 226958 p-
values) are identical to the above results in association studies yield
by using standard haplotypes as references. Statistically phased
haplotypes could serve well as haplotype references in our
approach.
In summary, we supplied an efficient approach to haplotype-
based GWAS. The approach delivers great power and no type I
error inflation to association studies. To the best our knowledge, it
is one of the most efficient approaches that have been published.
Materials and Methods
Approach to haplotype-based GWAS
The objective of the proposed method is to replace single SNP
marker with haplotypes of multiple SNPs for GWAS analysis. This
method involves three steps: SNP selection, phasing and statistical
test. The method was implemented in a C++ program, Haplominer.
Source codes of the program and related files could be
downloaded from website of sourceforge.net (http://haplominer.
sourceforge.net) or authors’ website (http://www.picb.ac.cn/
,yunganghe/haplominer). Details of the method were addressed
blow.
Select SNP clusters using a reference population. We
first identify SNPs with criteria of perfect phylogeny whose
haplotypes can be determined for association studies without
invoking recombination [26]. These SNPs are close to each other
but not necessarily contiguous. To boost speed of the identification
and avoid the complications involved in haplotype inference, SNP
selection is therefore suggested to be done using a reference
population with available haplotype information. For a proper
application of the method, it is important to ensure the ethnicity of
the population for SNP selection should match that of case-control
samples in an association study. In this report, we used CEU data
set from the International HapMap Project for SNP selection as an
example, in which highly reliable haplotypes were inferred from
trio samples.
For each given SNP, additional SNPs were selected based on
haplotypes of the reference population, to form a SNP cluster
whose haplotypes could be inferred without invoking recombina-
tion [26]. The SNP selection requires a given size of genomic
region (typically 5–30 kb) and a predetermined maximum number
of SNPs (typically 2–4 SNPs). An excessive number of SNPs may
result in a reduction of statistical power [3]. The additional SNPs
can be achieved by searching exhaustively all allowed SNP clusters
in the working region with the reference population, and the
cluster, therefore SNPs, yielding maximum entropy was selected.
It is of course important to select only the SNPs that are shared
between the reference population and the samples (including both
cases and controls) for GWAS analysis.
This exercise would yield a cluster of selected SNPs (or a SNP
combination) for each given SNP. Each SNP, which could now be
replaced by the haplotypes of the corresponding SNP cluster,
would be interrogated individually in the GWAS analysis. In this
report, the haplotypes observed in the reference population are
also referred to as ‘‘observed’’ haplotypes, otherwise ‘‘unobserved’’
haplotypes.
Haplotype identification in GWAS samples. For a SNP
cluster associated a given SNP, genotypes of a GWAS sample have
only one permitted solution (consisting of two observed haplotypes)
in the inference of haplotypes, theoretically. In other words, all
GWAS genotypes, including cases and controls, can be
deconvoluted uniquely into the observed haplotypes if the
reference population carries all the haplotypes in the GWAS
samples, typically when the reference population is large enough.
However, when the reference population is not sufficiently large, in
reality, we mayencounterunpermitted genotypes (consisting at least
one unobserved haplotypes) in GWAS samples, though rarely [27].
Most of the GWAS samples can be deconvoluted into observed
haplotypes (Figure 6). When this cannot be achieved, two
scenarios may arise. (1) The unpermitted genotypes can be
dissected into one observed haplotype and its’ complementary
haplotype. However, when multiple solutions are possible, the
observed haplotype with higher frequency in the reference
population is chosen. (2) The unpermitted genotypes can only be
explained by two unknown haplotypes. The unknown haplotypes
in both the scenarios do not damage further analysis because all
the unknown haplotypes will be pooled together for Pearson’s chi-
square test upon contingency table.
The phasing procedure could be presented below in pseudo
code.
#DEFINE an observed haplotype is a haplotype that
was observed in the reference panel for a given SNP
cluster
#DEFINE a permitted genotype is a genotype that
could be explained as a combination of two observed
haplotypes
#DEFINE unknown haplotypes are a group of
haplotypes which could not be identified in our phasing
An Efficient Method for Haplotype-Based GWAS
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one of the haplotype category.
IF the genotype of an individual for a given SNP cluster is a
permitted genotype
Unravel the genotype into two observed haplotypes
ELSE
IF the genotype could be explained as a combination of one
observed haplotype and its’ complementary haplotype
Unravel the genotype to one observed haplotype and its’
complementary haplotype
ELSE
Explain the genotype as the combination of two unknown
haplotypes
END
END
Statistical test. Pearson’s chi-square test is performed on a
contingency table with haplotype data in association study. In the
test, for each cluster with n SNP markers, counts of haplotypes in
case and control groups were organized into a m by 2 contingency
table (for example, m=n+2o rm = n +1 for scenarios with or
without unobserved haplotype). For each haplotype marker, all
unobserved haplotypes were pooled together to reduce degree of
freedom in the Pearson’s chi-square test.
Phasing performance
Evaluation with HapMap data. In order to evaluate
phasing performance of our method in real genotyping data, we
conducted cross-validations in the phase-known CEU data set
from HapMap Phase II. 60 unrelated individuals of the CEU
panel were randomly permutated and then assigned into 6 groups
with 10 individuals each. In each validation, haplotypes of 10
individuals in one of the groups were used as standard to evaluate
phasing quality while haplotypes of other 50 individuals served as
the reference panel. The validation began by selecting a set of SNP
clusters from the reference panel in the same manner described
above with a maximum cluster size of 3 and a window size of
20 kb. In our method, we reconstructed haplotypes for genotypes
of SNP clusters of the 10 individuals then compared to the
standard haplotypes.
Performance of our method on GWAS data
Performance on simulation data. In the evaluation, ten data
sets were generated in MaCS (http://www-hsc.usc.edu/,garykche/)
under the frame of coalescent theory [28]. We assumed Ne=5,000,
m=2 610
28 per bp, and r=1.2610
28 per bp. This translates to a
scaled mutation rate and recombination rate (scaled in units of 4Ne
generations) of 10,000 and 6000 for a 25-Mb region.
Each data set contains 2,200 chromosomes, 200 of which were
used as a phase-known reference panel. The rest 2,000
chromosomes were randomly assigned into case or control group
with 1,000 chromosomes each. In each group, genotypes of one
individual were determined by joining two randomly chosen
chromosomes. Only SNPs with minor allele frequency (MAF)
larger than or equal to 0.05 were used in further evaluation.
Our method and three representative phasing algorithms
(MACH: http://www.sph.umich.edu/csg/abecasis/MACH/, Bea-
gle: http://www.stat.auckland.ac.nz/,bbrowning/beagle/beagle.
html and 2SNP: http://alla.cs.gsu.edu/,software/2SNP/) were
evaluated in the simulation data set. For a high phasing quality, the
simulated genome fragments were phased as a whole (without
cutting to pieces) in the three representative phasing algorithms.
MACH and 2SNP did not show competitive efficiency in the initial
evaluation for timing cost. Only Beagle and our method were
included in further comparisons.
Using the simulation data, we selected SNP clusters and
calculated p-values for each of the SNP clusters in our method.
Figure 6. An example for haplotype identification with selected SNP cluster and phase-known reference population.
doi:10.1371/journal.pone.0022097.g006
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5,000 bp in size. Raw haplotypes or Beagle-generated haplotypes
for the selected SNP clusters were used to organize the simulated
case-control data into cross tables. Pearson’s chi-square test was
performed on the cross tables from a different approach to
corresponding p-values.
To rate performances in association study directly, we
compared accordant rate of p-values between our method and
Beagle-based approach. In this report, the accordant rate of a
specific approach is a proportion of its statistical tests that gave the
same p-value as the corresponding tests using raw haplotypes.
Performance on real data. A GWAS data set for
rheumatoid arthritis (RA) from the North American
Rheumatoid Arthritis Consortium (NARAC) was used to
evaluate our method [18]. SNP clusters were selected in the
phase-known CEU data set from HapMap Phase II with a given
maximum cluster size of 3 and a window size of 20 kb. Before any
further analysis, we conducted a multi-level data clean in PLINK
[14]. Individuals having cryptic family relationships or a rate of
genotype missing larger than 5% were excluded from association
analysis. SNP markers having minor allele frequency less than 1%
or missing data more than 5% were excluded. Furthermore, all
involving loci passed a statistical test for HWE with p-value larger
than or equal to 1610
25. After the data cleaning, 502,763 SNPs
remained from 859 cases and 1185 controls. The data set included
565 males and 1479 females. Both standard single-marker analysis
and our haplotype-based analysis were performed on the data set.
Positive findings on Chromosome 6 were visualized in
WGAViewer to present the power difference between the two
approaches [29].
We also validate the positive findings on Chromosome 6 using
WTCCC RA data sets [24]. About 80% of SNP markers on
Chromosome 6 from above RA genotyping data cannot be found
in WTCCC RA data due to the using of different genotyping
platforms. Genotype imputation was carried out in Beagle to fill
the missing genotypes in WTCCC RA data with HapMap CEU
data as a reference. We conducted association analysis on the
WTCCC RA data with both real and imputed genotypes using the
same approach that has been used for NARAC data analysis. The
positive findings from the above NARAC data analysis were
checked carefully using the WTCCC RA data for rate of
replication.
The institutional review board reviewed and approved the study
in accordance with the code of ethics of the World Medical
Association (Declaration of Helsinki).
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